Duke Radiation Oncology and Radiology Stimulating Access to Research in Residency

杜克大学放射肿瘤学和放射学促进住院医师研究的机会

基本信息

  • 批准号:
    10647795
  • 负责人:
  • 金额:
    $ 55.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-02-05 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Advances in imaging and radiation therapy have the potential to spark widespread improvements in cancer diagnosis and treatment. However, a major barrier to progress in Radiation Oncology and Radiology is a shortage of physician-scientists with the necessary training to make transformative discoveries. Therefore, there is an urgent need to develop novel pathways for extended mentored research to retain more radiation oncologists and radiologists in research. To address this gap, we propose a Duke Radiation Oncology and Radiology Stimulating Access to Research in Residency (Duke ROR StARR) Program, with its central mission to cultivate Resident-Investigators in Radiation Oncology and Radiology through protected time to perform mentored research, therefore creating a cadre of physician-scientists who will make future discoveries that advance imaging and treatment of cancer. With a multi-departmental strategy spanning clinical and basic science departments, Resident-Investigators will experience individualized, multifaceted, and continuous training, embedded within a robust, institutional framework for physician scientist support. A team of multi- disciplinary, well-funded faculty Preceptors, as well as a group of talented Rising Preceptors, offer research opportunities in areas along the cancer research continuum from basic radiation and cancer biology, to pre- clinical imaging and translational studies, to early phase clinical trials. These areas address NCI strategic research priorities that include dissecting pathobiological mechanisms of cancer and developing novel diagnostic and therapeutic strategies. The program will consist of five training Aims: (1) Comprehensive didactics on professional development and basic, translational, and clinical research; (2) A research project and individual career development plan; (3) Scholarly activity; (4) Board eligibility for the American Board of Radiology; and (5) A path for continued post-residency mentored research training with sub-specialty clinical development. Led by PI David Kirsch (Radiation Oncology), Associate Program Directors Joseph Lo (Radiology) and Scott Floyd (Radiation Oncology), and departmental Residency Program Directors, the program will support three Resident-Investigators in Radiation Oncology, Diagnostic Radiology and/or Interventional Radiology per year, who will complete 12-24 months of mentored research. Institutional support including resources from the Office of Physician Scientist Development, departmental salary support, a research supplement funded by the School of Medicine, and preferences for a subspecialty fellowship or research-intensive Instructor position at Duke supported by the Duke Cancer Institute will ensure that after completing the program, these individuals will be poised to become the next generation of physicians to lead research in Radiation Oncology and Radiology. Achieving the Program's objectives will fulfill urgent needs for: 1) more physician-scientists in Radiation Oncology and Radiology and 2) innovations in imaging, cancer biology, and radiation oncology to transform the lives of cancer patients.
成像和放射治疗的进步有可能引发癌症的广泛改善

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Factors Associated With New-Onset Seizures Following Stereotactic Radiosurgery for Newly Diagnosed Brain Metastases.
  • DOI:
    10.1016/j.adro.2022.101054
  • 发表时间:
    2022-11
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Lerner, Emily C;Srinivasan, Ethan S;Broadwater, Gloria;Haskell-Mendoza, Aden P;Edwards, Ryan M;Huie, David;Vaios, Eugene J;Floyd, Scott R;Adamson, Justus D;Fecci, Peter E
  • 通讯作者:
    Fecci, Peter E
Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery.
采用 5 分次立体定向放射外科治疗的完整脑转移瘤和已切除脑转移瘤患者的结果。
Prognostic Model for Intracranial Progression after Stereotactic Radiosurgery: A Multicenter Validation Study.
  • DOI:
    10.3390/cancers14215186
  • 发表时间:
    2022-10-22
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Carpenter, David J.;Natarajan, Brahma;Arshad, Muzamil;Natesan, Divya;Schultz, Olivia;Moravan, Michael J.;Read, Charlotte;Lafata, Kyle J.;Giles, Will;Fecci, Peter;Mullikin, Trey C.;Reitman, Zachary J.;Kirkpatrick, John P.;Floyd, Scott R.;Chmura, Steven J.;Hong, Julian C.;Salama, Joseph K.
  • 通讯作者:
    Salama, Joseph K.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Scott R Floyd其他文献

Scott R Floyd的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Scott R Floyd', 18)}}的其他基金

Duke Radiation Oncology and Radiology Stimulating Access to Research in Residency
杜克大学放射肿瘤学和放射学促进住院医师研究的机会
  • 批准号:
    10439573
  • 财政年份:
    2020
  • 资助金额:
    $ 55.88万
  • 项目类别:
Novel Targets for Stroke Intervention - Gene Discovery for Modulators of Infarction
中风干预的新靶点——梗死调节基因的发现
  • 批准号:
    10295761
  • 财政年份:
    2017
  • 资助金额:
    $ 55.88万
  • 项目类别:
Novel Targets for Stroke Intervention - Gene Discovery for Modulators of Infarction
中风干预的新靶点——梗死调节基因的发现
  • 批准号:
    10055780
  • 财政年份:
    2017
  • 资助金额:
    $ 55.88万
  • 项目类别:
High-content screening for modifiers of the DNA damage response
DNA 损伤反应调节剂的高内涵筛选
  • 批准号:
    7559378
  • 财政年份:
    2008
  • 资助金额:
    $ 55.88万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了